Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Daniel Cattran
ResearcherPublications, citations & collaboration network
Daniel Cattran is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 154 works, 12,055 citations, an h-index of 53 and an i10-index of 91.
154
Works
12,055
Citations
53
h-index
91
i10-index
IDs:OpenAlex
How has Daniel Cattran's publication output changed over time?
ScholarIQpublication output · 1999–2019
Output grew100% over the shown period — from 1 works in 1999 to 2 in 2019.
1
2
1
1
1
1
1
1
2
199920012007200920112012201520162019
What are the most-cited papers on Daniel Cattran?
ScholarIQmost cited works
The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility
A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Ian S.D. Roberts, H. Terence Cook, Stéphan Troyanov, Charles E. Alpers, Alessandro Amore, Jonathan Barratt, F. Berthoux, Stephen M. Bonsib, Jan A. Bruijn, Daniel Cattran, Rosanna Coppo, Vivette D. D’Agati, Giuseppe D’Amico, Steven N. Emancipator, Francesco Emma, John Feehally, Franco Ferrario, Fernando C. Fervenza, Sandrine Florquin, Agnes B. Fogo, Colin Geddes, Hermann-Josef Groene, Mark Haas, Andrew M. Herzenberg, Prue Hill, Ronald J. Hogg, Stephen I‐Hong Hsu, J. Charles Jennette, Kensuke Joh, Bruce A. Julian, Tetsuya Kawamura, Fernand Mac–Moune Lai, Lei-Shi Li, Philip Kam‐Tao Li, Zhi-Hong Liu, Bruce Mackinnon, Sergio Mezzano, Francesco Paolo Schena, Yasuhiko Tomino, Patrick D. Walker, Haiyan Wang, Jan J. Weening, Nori Yoshikawa, Hong Zhang
Kidney International. 20091,047 Citations
Remission of Proteinuria Improves Prognosis in IgA Nephropathy
Heather N. Reich, Ste[Combining Acute Accent]phan Troyanov, James W. Scholey, Daniel Cattran
Journal of the American Society of Nephrology. 2007635 Citations
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
Fernando C. Fervenza, Gerald B. Appel, Sean J. Barbour, Brad H. Rovin, Richard Lafayette, Nabeel Aslam, Jonathan Ashley Jefferson, Patrick E. Gipson, Dana V. Rizk, John R. Sedor, James F. Simon, Ellen T. McCarthy, Paul Brenchley, Sanjeev Sethi, Carmen Ávila-Casado, Heather Beanlands, John C. Lieske, David Philibert, Tingting Li, Leslie F. Thomas, Dolly F. Green, Luis A. Juncos, Lada Beara‐Lasić, Samuel S. Blumenthal, Amy N. Sussman, Stephen B. Erickson, Michelle Hladunewich, Pietro A. Canetta, Lee A. Hebert, Nelson Leung, Jay Radhakrishnan, Heather N. Reich, Samir V. Parikh, Debbie S. Gipson, Dominic K. Lee, Bruno R. da Costa, Peter Jüni, Daniel Cattran
New England Journal of Medicine. 2019605 CitationsOPEN ACCESS
Evaluating a New International Risk-Prediction Tool in IgA Nephropathy
Sean J. Barbour, Rosanna Coppo, Hong Zhang, Zhi-Hong Liu, Yusuke Suzuki, Keiichi Matsuzaki, Ritsuko Katafuchi, Lee Er, Gabriela Espino-Hernández, S. Joseph Kim, Heather N. Reich, John Feehally, Daniel Cattran, International IgA Nephropathy Network
JAMA Internal Medicine. 2019485 CitationsOPEN ACCESS
Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy
Laurence H. Beck, Fernando C. Fervenza, David M. Beck, Ramon Bonegio, Fahim Malik, Stephen B. Erickson, Fernando G. Cosio, Daniel Cattran, David J. Salant
Journal of the American Society of Nephrology. 2011471 CitationsOPEN ACCESS
Related on ScholarIQ
University of Toronto
Institution
The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility
Paper
Remission of Proteinuria Improves Prognosis in IgA Nephropathy
Paper
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
Paper
Evaluating a New International Risk-Prediction Tool in IgA Nephropathy
Paper
Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy
Paper